CHAL 35-Introduction to patent litigation in the United States

被引：0

作者：

Hasford, Justin J. ^{[1
]}

机构：

[1] Finnegan Henderson Farabow Garrrett & Dunner LLP, Washington, DC 20001 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 235卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

35-CHAL

引用

页数：1

共 50 条

[41] CHAL 31-Considering the obviousness standard for chemical composition inventions at the United States Patent and Trademark Office: Is it time for an objective standard?
Andrus, Alex
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[42] Foreign patent applications - A United States patent is effective only in the United States: Obtaining a foreign patent can be expensive and complex
Eisenberg, HM
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2001, 14 (05): : 76 - 77
[43] AIDS IN THE UNITED-STATES - EDUCATION AND LITIGATION
不详
LANCET, 1988, 1 (8588): : 779 - 779
[44] Litigation in the United States International Trade Commission
Bishop, Maximilienne
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[45] LITIGATION INVOLVING SPERM BANKING IN THE UNITED STATES
Herati, Amin
Stout, Thomas
Allison, Andrew
Cook, Peter
Lamb, Dolores
Lipshultz, Larry
JOURNAL OF UROLOGY, 2016, 195 (04): : E1160 - E1160
[46] Biosimilars in the United States: Emerging Issues in Litigation
Wong, Alice Yuen-Ting
Rumore, Martha M.
Chan, Albert Wai-Kit
BIODRUGS, 2017, 31 (03) : 189 - 205
[47] UNITED-STATES LITIGATION STYLE IN BRITAIN
BRAHAMS, D
LANCET, 1990, 335 (8693): : 847 - 848
[48] Consumer privacy regulation and litigation in the United States
Ambrose, SF
Gelb, JW
BUSINESS LAWYER, 2004, 59 (03): : 1251 - 1264
[49] MALPRACTICE LITIGATION AND MEDICAL COSTS IN THE UNITED STATES
Roberts, Brandon
Hoch, Irving
HEALTH ECONOMICS, 2009, 18 (12) : 1394 - 1419
[50] Biosimilars in the United States: Emerging Issues in Litigation
Alice Yuen-Ting Wong
Martha M. Rumore
Albert Wai-Kit Chan
BioDrugs, 2017, 31 : 189 - 205

← 1 2 3 4 5 →